Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification.
about
Magnetic resonance imaging for lung cancer screenDiffusion magnetic resonance imaging of chest tumors.Whole body MRI: improved lesion detection and characterization with diffusion weighted techniquesRestriction spectrum imaging: An evolving imaging biomarker in prostate MRI.A preliminary exploration of the intravoxel incoherent motion applied in the preoperative evaluation of mediastinal lymph node metastasis of lung cancer.Imaging in head and neck squamous cell carcinoma: the potential role of PET/MRI.Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience.Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer stagingApparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis.Lung magnetic resonance imaging with diffusion weighted imaging provides regional structural as well as functional information without radiation exposure in primary antibody deficiencies.MRI of the lung (2/3). Why … when … how?Characterization of malignant thrombus in an invasive thymoma with intravascular growth.Whole-body diffusion-weighted imaging for staging malignant lymphoma in children.Oncologic applications of diffusion-weighted MRI in the body.Apparent diffusion coefficient measurements in the differentiation between benign and malignant lesions: a systematic review.Diffusion weighted imaging in cystic fibrosis disease: beyond morphological imaging.Clinical PET-MR Imaging in Breast Cancer and Lung CancerDifferentiation of malignant and benign lung lesions with diffusion-weighted MR imaging.Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.Meta-analysis of diffusion-weighted MRI in the differential diagnosis of lung lesions.Amide proton transfer-weighted imaging to differentiate malignant from benign pulmonary lesions: Comparison with diffusion-weighted imaging and FDG-PET/CT.Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size.Performance of magnetic resonance imaging in pulmonary fungal disease compared to high-resolution computed tomography.Utility of diffusion-weighted MRI for differentiating acute from chronic cholecystitis.Imaging Lung Cancer by Using Chemical Exchange Saturation Transfer MRI With Retrospective Respiration Gating.Non-Gaussian diffusion imaging for malignant and benign pulmonary nodule differentiation: a preliminary study.Whole-body MRI-DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study.Diagnosed chest lesion on diffusion-weighted magnetic resonance images using apparent diffusion coefficients.Diffusion-weighted MRI of pulmonary lesions: Comparison of apparent diffusion coefficient and lesion-to-spinal cord signal intensity ratio in lesion characterization.Diffusion-weighted imaging can correctly identify false-positive lymph nodes on positron emission tomography in non-small cell lung cancer.Magnetic resonance imaging of pulmonary nodules: accuracy in a granulomatous disease-endemic region.Diffusion-weighted magnetic resonance imaging for assessment of lung lesions: repeatability of the apparent diffusion coefficient measurement.Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging.Role of the apparent diffusion coefficient measurement by diffusion weighted magnetic resonance imaging in the diagnosis of Fasciola hepatica in the liver.Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.MRI features of hepatocellular carcinoma expressing progenitor cell markers.Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm.FDG-PET/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors.Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
P2860
Q26829706-8A262828-14CC-4CB9-96E4-80009DFDFC96Q30575232-71A4852A-0FF7-48AB-89B6-BB39143DAD5AQ30662431-F60BB82D-2492-4DFD-9E60-8AC0218F73A4Q31121795-B61601B2-47DA-467B-B9B0-731848ADDA90Q33639210-0EE8D541-9802-4C6F-ABCA-3C4A328B2F80Q33792289-E3941B2A-62C7-4A35-A11E-01FBBB3AD646Q33913426-904E5EEE-3908-49B5-85AD-1D86A08469D4Q34683147-EB972CEA-C39D-4478-8916-85D3EA57E142Q35640148-95750072-7D67-4C83-8B37-C5AF56614F36Q35851600-1E413606-349A-41B7-B142-7FAC83365241Q36347046-B0F3C6BA-D00D-4856-8034-A54D23BE3F8BQ36866726-533D2A1A-95C0-474A-B992-3736B795D75FQ37777048-5A9FA568-3B26-48B3-A1C0-85E14833EE87Q37978220-17C612BD-6079-47DA-8A9C-6DEB03D6369AQ38018542-31E36E51-2392-4B0A-B12F-1E8A68FCD500Q38908611-7EE1D9B0-0181-4E2C-9DE6-9D77CD0755C3Q38945974-D07BC2D8-A1F9-4F82-9605-8BB1C306BA6FQ41823928-D778F106-D0A9-4A78-AAFF-B0FFE5522C7AQ42419373-46744527-B4FC-4C04-9460-6FF2EB7FB01EQ44275688-81129DF1-A8E1-47A7-A7E3-5E3D998D9A44Q46972235-851DB1BA-E0B4-4D20-89F8-7D7D23CE7F9DQ47406252-50B9FF68-87B8-4331-8EDF-22545CEE7262Q48002711-7585AAB0-33BA-454C-8B08-C091D0D7E4ACQ50157904-F8FDA4B3-A98E-4ED5-AC60-3A76D47C430AQ50281642-FC331915-B3F6-4C76-B45A-82866B68415CQ50672256-E255C1DE-892B-476A-AD0F-529630AD3A28Q50918860-F254CC45-71F1-44D9-8557-8108D38C15E4Q50929296-4A576F4C-73BF-4985-A136-9AD61BB54996Q51471582-BDF7337B-4EED-4E15-9B2F-28865F3AD0FCQ52986979-16A9146C-F300-4509-BEC6-C5850133EB25Q52987252-31749191-875B-434A-9135-F100FD2B15C5Q53087697-8837012C-2F6F-4BD9-A2B0-7348494A80CBQ53090152-01A7B84D-7BDD-4F31-B487-2FFDFD7AB985Q53090209-9840C3A4-AE5B-4530-B029-BBFC18BA9A85Q53153251-7B898CE5-3BFA-4C9C-B6D1-F3FCDBFEE976Q53398114-9B4EE538-EE17-4DF8-A9E7-AD4DD46E2CE6Q53418721-8A2F66D5-BC24-46FE-972C-E3F93D0C4F98Q53877538-FDEFC188-C9C1-4A97-BE25-DAEBC0BD9998Q55006459-512F0FEA-FF4A-4976-BDC4-D0F71255FE73Q55403242-B892DDF5-5EFC-444A-A116-252E7C5749AE
P2860
Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Higher sensitivity and specifi ...... on coefficient quantification.
@en
Higher sensitivity and specifi ...... on coefficient quantification.
@nl
type
label
Higher sensitivity and specifi ...... on coefficient quantification.
@en
Higher sensitivity and specifi ...... on coefficient quantification.
@nl
prefLabel
Higher sensitivity and specifi ...... on coefficient quantification.
@en
Higher sensitivity and specifi ...... on coefficient quantification.
@nl
P2093
P1433
P1476
Higher sensitivity and specifi ...... on coefficient quantification.
@en
P2093
Dai Hashimoto
Hirotoshi Nakamura
Kingo Chida
Naoki Inui
Takafumi Suda
Tateaki Naito
Tomohiro Uto
Yasuo Takehara
Yutaro Nakamura
P304
P356
10.1148/RADIOL.2521081195
P407
P577
2009-05-06T00:00:00Z